Weiss Scott L, Alexander Jamin, Agus Michael S D
Medicine Critical Care Program, Department of Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA.
Pediatr Emerg Care. 2010 Sep;26(9):626-32. doi: 10.1097/PEC.0b013e3181ef0488.
Although mild stress hyperglycemia in pediatric illness is common, severe hyperglycemic responses (≥300 mg/dL [16.7 mmol/L]) to stress are unusual. We sought to determine the incidence and course of extreme stress hyperglycemia (ESH) in acute pediatric illness, including whether it is a marker of increased mortality or associated with subsequent development of diabetes mellitus (DM).
We retrospectively reviewed a cohort of 55,120 consecutive visits over 6 years to a pediatric emergency department at which blood glucose concentrations were measured and report on visits with laboratory glucose 300 mg/dL (16.7 mmol/L) or greater without DM.
There were 72 cases of ESH (incidence of 0.13%). Median age was 8.8 years; 63% were male. The most common diagnoses were respiratory illness (49%), trauma (15%), and seizure (8%), and 65% of patients had received glucose-influencing interventions before evaluation. Eighty-five percent were ill appearing, 60% were admitted to the intensive care unit, and half had acidemic pH values. The overall mortality rate was 22%. Despite treatment of hyperglycemia in only 8 patients, glucose concentrations decreased to 150 mg/dL (8.3 mmol/L) or less within 48 hours in 67% and before discharge or death in 85% of patients. Preceding symptoms and concurrent laboratory results were helpful to exclude diabetes, and none of the surviving patients with follow-up available went on to develop type 1 or 2 DM.
Although rare, ESH (≥300 mg/dL [16.7 mmol/L]) does occur in acute pediatric illness, in most cases is at least partially iatrogenic, and is a marker of severe illness and high mortality. Normoglycemia is typically restored quickly with treatment of the primary illness. No association was found with a subsequent diagnosis of DM.
虽然小儿疾病中的轻度应激性高血糖很常见,但对压力产生严重高血糖反应(≥300mg/dL[16.7mmol/L])并不常见。我们试图确定急性小儿疾病中极端应激性高血糖(ESH)的发生率和病程,包括它是否是死亡率增加的标志或与随后糖尿病(DM)的发生有关。
我们回顾性分析了6年间连续到一家儿科急诊科就诊的55120例患者,这些患者均测量了血糖浓度,并报告血糖≥300mg/dL(16.7mmol/L)且无糖尿病的就诊情况。
共有72例ESH病例(发生率为0.13%)。中位年龄为8.8岁;63%为男性。最常见的诊断是呼吸系统疾病(49%)、创伤(15%)和癫痫发作(8%),65%的患者在评估前接受了影响血糖的干预措施。85%的患者有患病表现,60%的患者被收入重症监护病房,一半患者的pH值呈酸性。总体死亡率为22%。尽管仅8例患者接受了高血糖治疗,但67%的患者血糖浓度在48小时内降至150mg/dL(8.3mmol/L)或更低,85%的患者在出院或死亡前血糖浓度降至该水平。前驱症状和同时期的实验室检查结果有助于排除糖尿病,所有存活且有随访资料的患者均未发展为1型或2型糖尿病。
虽然罕见,但ESH(≥300mg/dL[16.7mmol/L])确实会在急性小儿疾病中出现,在大多数情况下至少部分是医源性的,并且是重症和高死亡率的标志。随着原发病的治疗,通常能迅速恢复正常血糖水平。未发现与随后诊断为糖尿病有关联。